HomeNKGNW • OTCMKTS
add
NKGen Biotech Inc.
Previous close
$0.0012
Market cap
2.49M USD
Avg Volume
2.72K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.10M | -45.93% |
Net income | -29.41M | 12.47% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.80M | 47.38% |
Effective tax rate | -0.18% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 106.00K | 307.69% |
Total assets | 16.23M | -1.52% |
Total liabilities | 86.14M | 14.59% |
Total equity | -69.91M | — |
Shares outstanding | 124.38M | — |
Price to book | -0.00 | — |
Return on assets | -81.66% | — |
Return on capital | 76.55% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -29.41M | 12.47% |
Cash from operations | -6.95M | -0.20% |
Cash from investing | -16.00K | 11.11% |
Cash from financing | 6.97M | 486.41% |
Net change in cash | -2.00K | 99.98% |
Free cash flow | -4.94M | 47.26% |
About
Founded
2017
Headquarters
Website
Employees
26
